Myriad respects your privacy and we never sell or distribute your information to third parties

Surgeons play key role in identifying patients at risk for hereditary colorectal cancer

Surgeons play key role in identifying patients at risk for hereditary colorectal cancer 

Hereditary colorectal cancer remains under-diagnosed.1 A recent study published inFamilial Cancer that investigated the gatekeeper role of surgeons in recognizing hereditary colorectal cancer identified a need to improve discussion of family history of cancer and referral for genetic counseling with patients diagnosed with colorectal cancer.2 The study considered sufficient family history discussions with patients to include:
  • evaluation of first- and second-degree relatives diagnosed with cancer
  • type and age of cancer diagnosis in relatives
  • if relevant, discussion of hereditary cancer syndromes
When examining details of discussions with patients on family history of cancer, the study showed that the quality of discussion was inadequate in 72% of consultations.2 Comprehensive evaluation of colorectal cancer patients’ family histories can help identify high-risk patients appropriate for genetic evaluation. Genetic testing can provide further insight into hereditary causes behind colorectal cancer and inform on potential medical management changes based on your patients’ individual future cancer risks. Content Divider

Myriad myRisk® Analyzes Several Genes Associated with Hereditary Colorectal Cancer


Click here for more information

References: 1. Singh H et al. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clinical Gastroenterology & Hepatology, 2010. 2. Douma K et al. Gatekeeper role of gastroenterologists and surgeons in recognizing and discussing familial colorectal cancer. Familial Cancer, December 2015.

Learn more about Hereditary Colorectal Cancer and Myriad myRisk®

If you have questions regarding this topic, please contact your local Regional Medical Specialist (RMS)


Myriad myRisk App

Find clinical information associated with Myriad’s myRisk cancer test.

Myriad Promise

Myriad promises to provide affordable access to testing.

Hereditary Cancer Quiz

Identify appropriate patients for hereditary cancer testing before or during your patient’s appointment.

Patient Education Videos

Guide your discussions with patients on hereditary cancer syndromes.

Search by Product

myChoice HRD myPath Melanoma myRisk Prolaris

Search by Cancer

Breast Colorectal Endometrial Lung Ovarian Prostate

Search by Specialty

Genetic Counselor Obstetrics and Gynecology Oncologist Primary Care Radiology


Myriad, the Myriad logo, MyriadPro, the MyriadPro logo, Myriad myRisk Hereditary Cancer, the Myriad myRisk Hereditary Cancer logo, Myriad myPath Melanoma, the Myriad myPath Melanoma logo, Myriad myPlan Lung Cancer, the Myriad myPlan Lung Cancer logo, BRACAnalysis, the BRACAnalysis logo, COLARIS, the COLARIS logo, COLARIS AP, the COLARIS AP logo, MELARIS, the MELARIS logo, PANEXIA, the PANEXIA logo, Prolaris, the Prolaris logo, ResultsNow, the ResultsNow logo, Myriad Promise, and the Myriad Promise logo are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions.